Balcinrenone/ dapagliflozin not checked
FollowEvery change as it happens, and a Monday email
Trials
2 active
6 in total · 3 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “1 capsule of balcinrenone/dapagliflozin 15 mg/10 mg and 1 tablet of matching placebo for dapagliflozin 10 mg once daily, oral use”In the company’s words, NCT06307652 on ClinicalTrials.gov
- Main trialPhase 3
- “This is a Phase III, international, multi-centre, randomised, double-blind, parallel-group, double-dummy, active-controlled, event-driven study in patients with chronic HF and impaired kidney function who had a recent HF event. The aim is to evaluate the effect of balcinrenone/dapagliflozin vs dapagliflozin, given once daily on top of other classes of SoC, on CV death and HF events.”In the company’s words, NCT06307652 on ClinicalTrials.gov
Other drugs for Heart Failure and Impaired Kidney Function
- DapagliflozinAstraZeneca · Phase 3
- HiCM-188HELP Therapeutics Co., Ltd. · Phase 3
- Omecamtiv MecarbilCytokinetics · Phase 3
- InclisiranNovartis Pharmaceuticals · Phase 3
- EmpagliflozinBoehringer Ingelheim · Phase 3
- VicadrostatBoehringer Ingelheim · Phase 3
Coming up2
- 16 Apr 2027Phase 3 trial completes · ClinicalTrials.gov
- 1 Jul 2030Phase 3 trial completes · ClinicalTrials.gov
Changes1
Last 90 days- 18 NovStatus changed: Recruiting to Active, not recruiting · ClinicalTrials.gov NCT06307652
Trials6
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Active, not recruiting | 16 Apr 2027 | Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function | |
| Phase 3Recruiting | 1 Jul 2030 | A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD) | |
| Phase 2Completed | 9 May 2025 | Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease | |
| Phase 1Completed | 28 Oct 2024 | A Phase I PK Study of Balcinrenone/Dapagliflozin in Healthy Chinese Participants | |
| Phase 1Completed | 12 Jul 2025 | A Study to Investigate the Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics in Fed and Fasted State and Pharmacokinetics of Balcinrenone When Dosed With a P-gp Inhibitor in Healthy Participants. | |
| Phase 1Completed | 6 Oct 2026 | Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/Dapagliflozin |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026